RxDoctor Payments Data

Kwun Wen, MD

Clinical Pathology/Laboratory Medicine · San Francisco, CANPI 1326307430

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $142,813 of the $142,813 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Exact Sciences. Reporting peaked in 2023 at $99,500 and has fallen 56.6% since, to $43,175 in 2025. Among clinical pathology/laboratory medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$142,813in general payments, 2019–2025

Across 20 payments — averaging $7140.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$143K

What the payments were for

  • Consulting fees$142,813100%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Exact Sciences20$142,813

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$142,813 in reported general payments places this provider in the 95th percentile of 58 clinical pathology/laboratory medicine providers in California.

See all clinical pathology/laboratory medicine providers in California

Medicare billing

Part B allowed, 2024
$76,478
Medicare patients
581
Services billed
1,865

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical pathology/laboratory medicine in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →